Will the revision of Directive 93/42/EEC concerning medical devices - scheduled for the end of the first semester of 2012 – fill the gaps in the text that led to the adulterated breast implants scandal? In essence, this is the written question...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
Warning: fwrite(): supplied argument is not a valid stream resource in /var/www/europolitics/site/components/com_xg/views/article/tmpl/default.php on line 482
Warning: fclose(): supplied argument is not a valid stream resource in /var/www/europolitics/site/components/com_xg/views/article/tmpl/default.php on line 483
Pharmaceutical industry spends 40 mn euro on lobbying - 05/04/2012
Employers oppose directive on musculoskeletal disorders - 05/04/2012
Cigarettes: Neutral packaging still an option - 05/04/2012
Pharmacovigilance: MEPs want to move quickly - 26/03/2012
Import controls on food from Japan fine-tuned - 26/03/2012
Pessimistic preliminary assessment of national strategies - 23/03/2012
ENVI committee suggests use of register - 23/03/2012
Pharmaceutical industry spends 40 mn euro on lobbying - 
